Overview

A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of abicipar pegol in patients with diabetic macular edema.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Ranibizumab